Filing Flows › Health Care › Functional Brands (MEHA)
Functional Brands (MEHA) earnings and revenue breakdown
Latest: Q2 2026 · 10-Q filed Aug 14, 2026 · Functional Brands (MEHA) Q2 2026 earnings results →
Q2 2026 Revenue up 2% year over year to $1.9M · 141¢ of every $1 of revenue lost · operating margin -70.6%
Functional Brands made $1.9M in Q2 2026 (+2% Y/Y). Operating margin -70.6%, net loss $2.6M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 14, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $1.9M in Q2 2026, up 2% year over year and up 14% from the previous quarter.
Gross margin was 59.9%, up 7.1 points from a year earlier. Operating costs exceeded revenue by $1.3M, an operating margin of -70.6%. Operating expenses grew 117% against revenue growth of 2%. The fastest-growing cost line was General & admin (+119%). The quarter ended with a net loss of $2.6M, narrower than the previous quarter's $7.0M loss.
Operating cash flow was −$519K. Non-cash charges added back $16K of depreciation and amortization and $315K of share-based compensation. Working capital and other items added $1.8M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10-Q | Aug 14, 2026 | $1.9M | +2% | -70.6% | −$2.6M | −$519K |
| Q1 2026 | 10-Q | May 15, 2026 | $1.6M | +4% | -41.5% | −$7.0M | −$425K |
| Q4 2025 | 10-K | Mar 27, 2026 | $1.5M | -11% | -75.8% | $852K | −$2.7M |
| Q3 2025 | 10-Q | Dec 15, 2025 | $1.7M | +21% | -4.6% | $259K | $831K |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Functional Brands
Our company operates in the nutraceutical supplement industry. We are a manufacturer and distributor of supplements in categories such as pain, energy, prenatal, general health, bone and joint, gastro, immunity, cardiac, detox, mental clarity & focus, sleep, prenatal and urinary. Our end markets focus on end-consumers through different channels that include pharmacies, US wholesalers, international distributors and direct-to-consumers sales. Our products are sold over the counter, and consumers do not need a prescription to purchase our products. Our products are not approved by the FDA. Our principal business is the production, marketing, sales, and distribution of nutraceutical products through our Kirkman division. We ship our Kirkman products to throughout the United States and to 35 countries.
In its own words, from its 10-K, filed Mar 27, 2026.
Functional Brands against its Medicinal Chemicals & Botanical Products peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +2% against the peers' median +7%. Operating margin: -70.6% against the peers' median 0.8%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| MEHA Functional Brands | Q2 2026 | $1.9M | +2% | -70.6% |
| CURLF Curaleaf Holdings | Q3 2026 | $353M | +11% | 0.8% |
| TLRY Tilray Brands | Q1 FY27 | $257M | +23% | -9.4% |
| TRLV Trulieve Cannabis | Q3 2026 | $230M | -20% | 18.5% |
| USNA Usana Health Sciences | Q2 2026 | $223M | -5% | -9.0% |
| AAWH Ascend Wellness Holdings | Q2 2026 | $126M | -0.9% | 4.2% |
| CRON Cronos Group | Q3 2026 | $83.9M | +72% | 10.8% |
| CGC Canopy Growth | Q2 FY27 | $71.1M | +20% | -23.1% |
| JUSH Jushi Holdings | Q3 2026 | $70.5M | +7% | 5.0% |
Source: Functional Brands 10-Q on SEC EDGAR · CIK 1837254 · Medicinal Chemicals & Botanical Products
13F: who owns MEHA and who is buying
More on MEHA
History
Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results